![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Keith Humphreys | |
---|---|
![]() Professor Keith Humphreys |
Keith Humphreys (born 1966 in West Virginia [1] ) is an American psychologist who is currently the Esther Ting Memorial Professor at Stanford University, [2] a Senior Research Career Scientist in the Veterans Health Administration, [2] and an Honorary Professor at the Institute of Psychiatry, King's College, London. [3]
He is known for his scholarly work in the public & political spheres, having advised multiple international administrations on Additiction policy, and won awards for his educational public policy & health books regarding Addiction. [4] He is The Deputy Editor in Chief [5] for the journal Addiction. Humphreys won the 2021 Under Secretary's Award for Outstanding Achievement in Health Services Research from the U.S. Department of Veterans Affairs. [6]
He obtained his B.A. from Michigan State University and his A.M. from University of Illinois from 1991 followed by his Ph.D. there in 1993. [7]
In his widely-cited book, Circles of Recovery, Humphreys synthesized extensive evidence that a broad range of mutual help groups benefit individuals with substance use disorders. This included traditional 12-step mutual help organizations like Narcotics Anonymous, non-12 step groups like Women for Sobriety, and non-abstinence oriented groups such as Moderation Management. He was a member of the team that in 2020 released the Cochrane Systematic Review of Alcoholics Anonymous Research, which attracted widespread media attention as the strongest evidence to date of the benefits of Alcoholics Anonymous participation. For his research on self-help groups and treatments for substance use disorders, Humphreys won the 2021 VA Undersecretary of Health's Award for Outstanding Achievement in Health Services Research.
Humphreys served as a Member of the White House Commission on Drug-Free Communities under President George W. Bush. He also served as Senior Policy Advisor at the White House Office of National Drug Control Policy (ONDCP) during the passage of the Affordable Care Act, which included full coverage for the treatment of addiction. Since leaving The White House, he has continued to be involved in federal policy deliberations, including being a senior editor of U.S. Surgeon General Vivek Murthy’s report Facing Addiction in America, testifying to the House Committee on Government Reform about the mission and structure of ONDCP, testifying to the House Subcommittee on Crime, Immigration, and Border Security about the lack of evidence that sanctuary cites contribute to the opioid epidemic, testifying to the U.S Senate Drug Policy Caucus about the opioid epidemic, and advising Congress on the 2018 Support for Patients and Communities Act.
In many television and newspaper interviews, Humphreys has been highly critical of the role of Purdue Pharma and other opioid manufacturers in starting the opioid epidemic. He has also been critical of the Trump Administration's response to the epidemic, which he told CBS News was a “complete failure”.
Humphreys worked with California Lt. Governor Gavin Newsom on the Blue Ribbon Commission on Marijuana Law and Policy, which recommended that public health and youth protection be higher priorities than corporate profit if California legalized marijuana. He also served on the team led by drug policy expert Mark Kleiman that advised the State of Washington how to effectively regulate the marijuana industry after that state legalized. Both Kleiman and Humphreys rejected as a false dichotomy the choice between criminal punishment of marijuana users and an unregulated profit seeking corporate sector creating a clone of the tobacco industry. In an interview with Bill Keller of The Marshall Project, Kleiman and Humphreys also agreed that newly legalized marijuana products are highly potent and probably have different effects than marijuana of prior eras. Humphreys has also been critical of the medical marijuana industry for encouraging opioid addicted individuals to replace their FDA approved medications with marijuana and for making false claims about the ability of marijuana to cure cancer, Alzheimer's Disease, and other serious illnesses.
Humphreys has also been extensively involved in British drug and alcohol policy. This has included advising the London Greater Authority on the establishment of mandatory sobriety programs for alcohol-involved offenders, serving on Professor Dame Carol Black’s independent review of British drug policy, and being a member of Baroness Ilora Finlay‘s Commission on Alcohol Harm. In 2022, Queen Elizabeth II made Humphreys an Honorary Officer of the British Empire to recognize his service to addiction science and policy in Britain.
Humphreys founded and currently co-directs the Stanford Network on Addiction Policy, which brings addiction researchers and policymakers to create better policies toward addiction. Current members include Fmr. State Senator Dan Foster, California Supreme Court Justice Mariano-Florentino Cuellar, California Assembly Minority Leader Marie Waldron, and Huntington, West Virginia Mayor Steve Williams.
Humphreys frequently writes for a general audience about addiction, mental health, criminal justice, and drug policy. Since 2014, he has been a regular contributor at Washington Post. [8] He has also published articles in The New York Times , [9] Wall Street Journal, [10] The Huffington Post , [11] and The Guardian . [12]
Recreational drug use is the use of one or more psychoactive drugs to induce an altered state of consciousness, either for pleasure or for some other casual purpose or pastime. When a psychoactive drug enters the user's body, it induces an intoxicating effect. Recreational drugs are commonly divided into three categories: depressants, stimulants, and hallucinogens.
Patrick Joseph Kennedy II is an American retired politician and mental health advocate. From 1995 to 2011, he served as a Democratic member of the United States House of Representatives from Rhode Island's 1st congressional district, and was the first Generation X member of congress when he was elected in 1995. He is a former member of the Opioid and Drug Abuse Commission and a co-founder of One Mind, a mental health nonprofit.
Driving under the influence (DUI) is the offense of driving, operating, or being in control of a vehicle while impaired by alcohol or drugs, to a level that renders the driver incapable of operating a motor vehicle safely. Multiple other terms are used for the offense in various jurisdictions.
The Office of National Drug Control Policy (ONDCP) is a component of the Executive Office of the President of the United States.
Drug czar is an informal name for the person who directs drug-control policies in various areas. The term follows the informal use of the term czar in U.S. politics. The 'drug czar' title first appeared in a 1982 news story by United Press International that reported that, "[United States] Senators ... voted 62–34 to establish a 'drug czar' who would have overall responsibility for U.S. drug policy." Since then, several ad hoc executive positions established in both the United States and United Kingdom have subsequently been referred to in this manner.
The war on drugs is the policy of a global campaign, led by the United States federal government, of drug prohibition, military aid, and military intervention, with the aim of reducing the illegal drug trade in the United States. The initiative includes a set of drug policies that are intended to discourage the production, distribution, and consumption of psychoactive drugs that the participating governments, through United Nations treaties, have made illegal.
Commonly-cited arguments for and against the prohibition of drugs include the following:
Mark Albert Robert Kleiman was an American professor, author, and blogger who dealt with issues of drug and criminal justice policy.
In the United States, the non-medical use of cannabis is legalized in 24 states and decriminalized in 7 states, as of November 2023. Decriminalization refers to a policy of reduced penalties for cannabis offenses, typically involving a civil penalty for possessing small amounts, instead of criminal prosecution or the threat of arrest. In jurisdictions without penalty the policy is referred to as legalization, although the term decriminalization is sometimes used for this purpose as well.
Drug addiction recovery groups are voluntary associations of people who share a common desire to overcome their drug addiction. Different groups use different methods, ranging from completely secular to explicitly spiritual. Some programs may advocate a reduction in the use of drugs rather than outright abstention. One survey of members found active involvement in any addiction recovery group correlates with higher chances of maintaining sobriety. Although there is not a difference in whether group or individual therapy is better for the patient, studies show that any therapy increases positive outcomes for patients with substance use disorders. The survey found group participation increased when the individual members' beliefs matched those of their primary support group. Analysis of the survey results found a significant positive correlation between the religiosity of members and their participation in twelve-step programs and to a lesser level in non-religious SMART Recovery groups, the correlation factor being three times smaller for SMART Recovery than for twelve-step addiction recovery groups. Religiosity was inversely related to participation in Secular Organizations for Sobriety.
Substance abuse prevention, also known as drug abuse prevention, is a process that attempts to prevent the onset of substance use or limit the development of problems associated with using psychoactive substances. Prevention efforts may focus on the individual or their surroundings. A concept that is known as "environmental prevention" focuses on changing community conditions or policies so that the availability of substances is reduced as well as the demand. Individual Substance Abuse Prevention, also known as drug abuse prevention involves numerous different sessions depending on the individual to help cease or reduce the use of substances. The time period to help a specific individual can vary based upon many aspects of an individual. The type of Prevention efforts should be based upon the individual's necessities which can also vary. Substance use prevention efforts typically focus on minors and young adults – especially between 12–35 years of age. Substances typically targeted by preventive efforts include alcohol, tobacco, marijuana, inhalants, coke, methamphetamine, steroids, club drugs, and opioids. Community advocacy against substance use is imperative due to the significant increase in opioid overdoses in the United States alone. It has been estimated that about one hundred and thirty individuals continue to lose their lives daily due to opioid overdoses alone.
Kevin Abraham Sabet is a former three-time White House Office of National Drug Control Policy advisor, having been the only person appointed to that office by both a Republican and Democrat. He is also an assistant professor adjunct at Yale University Medical School, a fellow at Yale's Institution for Social and Policy Studies, and a columnist at Newsweek.
This is a history of drug prohibition in the United States.
Michael P. Botticelli is an American public health official who served as the director of the White House Office of National Drug Control Policy (ONDCP) from March 2014 until the end of President Obama's term. He was named acting director after the resignation of Gil Kerlikowske, and received confirmation from the United States Senate in February 2015. Prior to joining ONDCP, he worked in the Massachusetts Department of Public Health. Following completion of his service as ONDCP Director, he became the executive director of the Grayken Center for Addiction Medicine at the Boston Medical Center.
The cannabis policy of the Reagan administration involved affirmation of the War on Drugs, government funded anti-cannabis media campaigns, expanded funding for law enforcement, involvement of the U.S. military in interdiction and eradication, reduction in emphasis in drug treatment, and creation of new Federal powers to test employees and seize cannabis-related assets.
Tim Ryan is an American activist, drug abuse interventionist, author and speaker. He is the Founder and Executive director of “A Man in Recovery” foundation. According to the National Safety Council, Ryan is notable for his position in favor of Drug policy reform and as a proponent of legislative change in American drug policy. His work was the subject of the A&E series “Dope Man” in July 2017. Ryan is also the author of the 2017 memoir From Dope to Hope: A Man in Recovery.
Anna Lembke is an American psychiatrist who is Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University. She is a specialist in the opioid epidemic in the United States, and the author of Drug Dealer, MD, How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Her latest book, a New York Times bestseller, Dopamine Nation: Finding Balance in the Age of Indulgence, was released in August 2021.
Rahul Gupta is an American physician from the state of West Virginia. In 2021, he was appointed to serve as director of the Office of National Drug Control Policy by President Joe Biden. He formerly served at the helm of the West Virginia Bureau for Public Health.
John F. Kelly is an American-based researcher and professor of addiction medicine at Harvard Medical School. He is the Founder and Director of the Massachusetts General Hospital Recovery Research Institute, Associate Director of the MGH Center for Addiction Medicine, and Program Director of the MGH Addiction Recovery Management Service.
Regina LaBelle is a professor and the director of the Addiction and Public Policy Initiative at the Georgetown University Law Center's O’Neill Institute for National and Global Health Law. She was the acting director of the White House Office of National Drug Control Policy (ONDCP) from January 20, 2021 to November 5, 2021, and the only woman to ever lead this office. She was named deputy director and served as acting director by President Joe Biden on the first day of his presidency. Prior to her work with the Biden Administration, she was the Chief of Staff of ONDCP under President Barack Obama.